Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its ...
Wearable device data may help detect and track idiopathic pulmonary arterial hypertension, a rare lung disease, a study ...
Tectonic Therapeutic is reviving relaxin biology with TX45, targeting Group 2 Pulmonary Hypertension with HFpEF. Check out ...
Cautionary Language Concerning Forward-Looking Statements ...
MyChesCo on MSN
Inhibikase enrolls first patient in phase 3 PAH trial
WILMINGTON, DE — Inhibikase Therapeutics Inc. (Nasdaq: IKT) has enrolled the first patient in its Phase 3 clinical trial ...
Youngstown State University will host an evening with Dr. Rana Awdish, a nationally recognized pulmonary and critical care physician and author, 6 to 7 p.m. April 23 in the recital hall of Bliss Hall.
Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.
New findings reveal pulmonary arterial hypertension may affect the brain early. Learn how inflammation and cognitive decline ...
In patients with post- and precapillary pulmonary hypertension and heart failure with preserved ejection fraction, ...
A recent study published in CHEST found that treatment-naïve adults with obesity-hypoventilation syndrome receiving a ...
AllRock Bio has dosed the first patients in the Phase IIa ROCSTAR clinical trial investigating ROC-101, an oral ...
Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) Annual Scientific Session and Expo in New Orleans, March 28 to 30. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results